Catalyst Wire Dossier Catalyst Wire Dossier

RUXIENCE

RITUXIMAB-PVVR · Pfizer Laboratories Div Pfizer Inc
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for RUXIENCE, covering 2019-07-23 to 2025-07-14. Get the full timeline:

Most recent: EMA Authorised: Ruxience (rituximab) — Pfizer Europe MA EEIG

See pricing